bimatoprost 0.03%

DRUG10 trials

Conditions

CataractEyelash HypotrichosisGlaucomaGlaucoma, Open-AngleOcular HypertensionOpen Angle GlaucomaOpen-Angle GlaucomaOpen-angle Glaucoma

Phase 1

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

CompletedNCT01157364

AllerganOcular Hypertension, Open-Angle Glaucoma

Start: 2010-09-23End: 2016-08-09Updated: 2020-03-30

Phase 2

Safety and Efficacy of a Drug Delivery System in Glaucoma

CompletedNCT01016691

Vistakon PharmaceuticalsOcular Hypertension, Open-angle Glaucoma

Start: 2009-10-31Updated: 2015-03-06

Phase 3

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

CompletedNCT01830140

AllerganGlaucoma, Ocular Hypertension

Start: 2013-07-31End: 2014-05-31Updated: 2015-05-06

Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues

CompletedNCT02155049

Rabin Medical CenterThyroid Associated Ophthalmopathies

Start: 2014-11-30End: 2017-05-31Updated: 2018-02-19

Phase 4

Lumigan Versus Cosopt

CompletedNCT00273455

Pharmaceutical Research NetworkOpen-Angle Glaucoma

Start: 2006-01-31End: 2007-05-31Target: 34Updated: 2008-11-19

Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.

CompletedNCT00355446

Indiana University School of MedicineCataract

Start: 2001-07-31End: 2004-10-31Target: 48Updated: 2007-10-17

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

CompletedNCT00539526

AllerganOcular Hypertension, Open Angle Glaucoma

Start: 2007-09-30End: 2008-09-30Updated: 2019-04-24

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

CompletedNCT01229423

AllerganEyelash Hypotrichosis

Start: 2009-11-30End: 2010-10-31Updated: 2019-01-29

A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension

CompletedNCT02061683

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2010-04-19End: 2011-06-24Updated: 2019-04-18

Unknown Phase

An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

CompletedNCT01623479

AllerganEyelash Hypotrichosis

Start: 2010-11-19End: 2011-09-01Updated: 2019-04-16

Related Papers

Single Administration of Intracameral Bimatoprost Implant 10 µg in Patients with Open-Angle Glaucoma or Ocular Hypertension

Ophthalmology and Therapy2022-05-2827 citations

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

Drugs2019-12-2896 citations